(Q43582607)

24 November 2017

The muscarinic agonist xanomeline increases monoamine release and immediate early gene expression in the rat prefrontal cortex (English)

1 reference

24 November 2017

1 reference

Perry KW

1

1 reference

24 November 2017

Nisenbaum LK

2

1 reference

24 November 2017

George CA

3

1 reference

24 November 2017

Shannon HE

4

1 reference

24 November 2017

Felder CC

5

1 reference

24 November 2017

Bymaster FP

6

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

24 November 2017

Biological Psychiatry

1 reference

24 November 2017

49

1 reference

24 November 2017

8

1 reference

24 November 2017

716-725

1 reference

Drug-induced changes of dopamine turnover in striatum and limbic system of the rat

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane .

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Potential role of muscarinic receptors in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Physostigmine ameliorates the delusions of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Effect of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism: an in vivo microdialysis study comparing normal and 6-hydroxydopamine-lesioned rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Effects of typical and atypical neuroleptics on Fos protein expression in the rat forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Activation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: an in vivo electrophysiological study in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

M1 muscarinic antagonists interact with sigma recognition sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Muscarinic receptor-mediated induction of Fos protein in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Activation of pirenzepine-sensitive muscarinic receptors induces a specific pattern of immediate-early gene expression in rat brain neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Organization of catecholamine neurons projecting to the frontal cortex in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Acetylcholinesterase-rich neurons of the human cerebral cortex: cytoarchitectonic and ontogenetic patterns of distribution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Differential cholinergic innervation within functional subdivisions of the human cerebral cortex: a choline acetyltransferase study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Effect of oxotremorine on homovanillic acid concentration in the striatum of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Effects of olanzapine on regional C-Fos expression in rat forebrain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Muscarinic agonists with antipsychotic-like activity: structure-activity relationships of 1,2,5-thiadiazole analogues with functional dopamine antagonist activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Olanzapine-induced Fos expression in the rat forebrain; cross-tolerance with haloperidol and clozapine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Topography of serotonin neurons in the dorsal raphe nucleus that send axon collaterals to the rat prefrontal cortex and nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Sequence and significance of dopamine metabolism in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2901017-9

10.1016/S0006-3223(00)01017-9

7 January 2021

Identifiers

DOI

1 reference

24 November 2017

1 reference